12 September 2025
12 September 2025
The healthcare editorial team unpicks several key trials and trends from this year's ESC Congress.
The US-based pharma has scrapped its UK expansion plans due to the government's lack of investment in the life sciences sector.
Zentiva's operations span the development, production and distribution of medicines in more than 30 countries.
AbbVie has signed deals with Rinvoq generic hopefuls as it extends protection for one of its prized assets until 2037.
CRISTÁLIA will manage the licensing, distribution and commercialisation efforts of the biosimilar in the region.
A new report by the BPI outlines an alarming drop in British life sciences investment as companies increasingly turn elsewhere.
The capital is earmarked for the advancement of trials across various therapeutic domains.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
